問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-10-01 - 2027-10-01
Condition/Disease
Test Drug
Participate Sites10Sites
Recruiting10Sites
2018-08-01 - 2025-12-31
2023-12-01 - 2029-04-30
Participate Sites9Sites
Recruiting9Sites
2021-07-14 - 2027-04-17
Participate Sites4Sites
Recruiting4Sites
2022-01-01 - 2024-07-31
Locally Advanced or Metastatic Unresectable Urothelial Cancer
Sacituzumab Govitecan
Participate Sites11Sites
Recruiting11Sites
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2021-11-01 - 2025-12-31
2021-10-22 - 2023-07-14
Participate Sites5Sites
Recruiting5Sites
2022-05-02 - 2023-04-18
2019-08-09 - 2026-12-31
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Ponatinib
Recruiting3Sites
全部
